Hydroxychloroquine in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer

NCT00726596 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: hydroxychloroquine

Sponsor

Rutgers, The State University of New Jersey

Collaborators

[object Object]
[object Object]